98 related articles for article (PubMed ID: 22865198)
1. Three-dimensional vascular mapping of the breast by using contrast-enhanced MRI: association of unilateral increased vascularity with ipsilateral breast cancer.
Orgüç Ş; Başara I; Coşkun T; Pekindil G
Diagn Interv Radiol; 2012; 18(5):454-9. PubMed ID: 22865198
[TBL] [Abstract][Full Text] [Related]
2. Gadobenate dimeglumine-enhanced MR imaging breast vascular maps: association between invasive cancer and ipsilateral increased vascularity.
Sardanelli F; Iozzelli A; Fausto A; Carriero A; Kirchin MA
Radiology; 2005 Jun; 235(3):791-7. PubMed ID: 15845796
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced MR angiography of the breast: Evaluation of ipsilateral increased vascularity and adjacent vessel sign in the characterization of breast lesions.
Kul S; Cansu A; Alhan E; Dinc H; Reis A; Çan G
AJR Am J Roentgenol; 2010 Nov; 195(5):1250-4. PubMed ID: 20966336
[TBL] [Abstract][Full Text] [Related]
4. Gadolinium-enhanced MR angiography of the breast: is breast cancer associated with ipsilateral higher vascularity?
Mahfouz AE; Sherif H; Saad A; Taupitz M; Filimonow S; Kivelitz D; Hamm B
Eur Radiol; 2001; 11(6):965-9. PubMed ID: 11419172
[TBL] [Abstract][Full Text] [Related]
5. The lactating breast: contrast-enhanced MR imaging of normal tissue and cancer.
Espinosa LA; Daniel BL; Vidarsson L; Zakhour M; Ikeda DM; Herfkens RJ
Radiology; 2005 Nov; 237(2):429-36. PubMed ID: 16244250
[TBL] [Abstract][Full Text] [Related]
6. Increased ipsilateral whole breast vascularity as measured by contrast-enhanced magnetic resonance imaging in patients with breast cancer.
Wright H; Listinsky J; Quinn C; Rim A; Crowe J; Kim J
Am J Surg; 2005 Oct; 190(4):576-9. PubMed ID: 16164924
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced 3.0-T breast MRI for characterization of breast lesions: increased specificity by using vascular maps.
Schmitz AC; Peters NH; Veldhuis WB; Gallardo AM; van Diest PJ; Stapper G; van Hillegersberg R; Mali WP; van den Bosch MA
Eur Radiol; 2008 Feb; 18(2):355-64. PubMed ID: 17882425
[TBL] [Abstract][Full Text] [Related]
8. Breast contrast-enhanced MR imaging: semiautomatic detection of vascular map.
Fusco R; Sansone M; Filice S; Petrillo A
Breast Cancer; 2016 Mar; 23(2):266-72. PubMed ID: 25239166
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the enhancing lesions on dynamic contrast enhanced magnetic resonance imaging in patients with interstitial mammoplasty.
Kim TY; Kim SH; Kang BJ; Kim HS; Cha ES; Kim JY; Song BJ
Eur J Radiol; 2013 Dec; 82(12):2205-11. PubMed ID: 24103354
[TBL] [Abstract][Full Text] [Related]
10. Invasive carcinomas and fibroadenomas of the breast: comparison of microvessel distributions--implications for imaging modalities.
Weind KL; Maier CF; Rutt BK; Moussa M
Radiology; 1998 Aug; 208(2):477-83. PubMed ID: 9680579
[TBL] [Abstract][Full Text] [Related]
11. Contrast-enhanced MR imaging of the breast: association between asymmetric increased breast vascularity and ipsilateral cancer in a consecutive series of 197 patients.
Verardi N; Di Leo G; Carbonaro LA; Fedeli MP; Sardanelli F
Radiol Med; 2013 Mar; 118(2):239-50. PubMed ID: 22872456
[TBL] [Abstract][Full Text] [Related]
12. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.
Kvistad KA; Rydland J; Vainio J; Smethurst HB; Lundgren S; Fjøsne HE; Haraldseth O
Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584
[TBL] [Abstract][Full Text] [Related]
13. Variation of breast vascular maps on dynamic contrast-enhanced MRI after primary chemotherapy of locally advanced breast cancer.
Martincich L; Bertotto I; Montemurro F; Ponzone R; Carbonaro LA; Regge D; Sardanelli F
AJR Am J Roentgenol; 2011 May; 196(5):1214-8. PubMed ID: 21512094
[TBL] [Abstract][Full Text] [Related]
14. Detection of breast malignancy: diagnostic MR protocol for improved specificity.
Huang W; Fisher PR; Dulaimy K; Tudorica LA; O'Hea B; Button TM
Radiology; 2004 Aug; 232(2):585-91. PubMed ID: 15205478
[TBL] [Abstract][Full Text] [Related]
15. Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer.
Su MY; Cheung YC; Fruehauf JP; Yu H; Nalcioglu O; Mechetner E; Kyshtoobayeva A; Chen SC; Hsueh S; McLaren CE; Wan YL
J Magn Reson Imaging; 2003 Oct; 18(4):467-77. PubMed ID: 14508784
[TBL] [Abstract][Full Text] [Related]
16. T1-weighted 3D dynamic contrast-enhanced MRI of the breast using a dual-echo Dixon technique at 3 T.
Dogan BE; Ma J; Hwang K; Liu P; Yang WT
J Magn Reson Imaging; 2011 Oct; 34(4):842-51. PubMed ID: 21769987
[TBL] [Abstract][Full Text] [Related]
17. Can the patient with cirrhosis be imaged for hepatocellular carcinoma without gadolinium?: Comparison of combined T2-weighted, T2*-weighted, and diffusion-weighted MRI with gadolinium-enhanced MRI using liver explantation standard.
Hardie AD; Kizziah MK; Rissing MS
J Comput Assist Tomogr; 2011; 35(6):711-5. PubMed ID: 22082541
[TBL] [Abstract][Full Text] [Related]
18. Frequency, upgrade rates, and characteristics of high-risk lesions initially identified with breast MRI.
Strigel RM; Eby PR; Demartini WB; Gutierrez RL; Allison KH; Peacock S; Lehman CD
AJR Am J Roentgenol; 2010 Sep; 195(3):792-8. PubMed ID: 20729462
[TBL] [Abstract][Full Text] [Related]
19. Prognostic role of MRI enhancement features in patients with breast cancer: value of adjacent vessel sign and increased ipsilateral whole-breast vascularity.
Han M; Kim TH; Kang DK; Kim KS; Yim H
AJR Am J Roentgenol; 2012 Oct; 199(4):921-8. PubMed ID: 22997388
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted magnetic resonance imaging of breast lesions: first experiences at 3 T.
Lo GG; Ai V; Chan JK; Li KW; Cheung PS; Wong TT; Ma M; Lee R; Chien D
J Comput Assist Tomogr; 2009; 33(1):63-9. PubMed ID: 19188787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
